Ashwin Shahir

home / authors / ashwin-shahir

Articles

31 Adjuvant Abemaciclib Plus Endocrine Therapy for HR+, HER2–, High-Risk Early Breast Cancer: Results From a Preplanned MonarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

31 Adjuvant Abemaciclib Plus Endocrine Therapy for HR+, HER2–, High-Risk Early Breast Cancer: Results From a Preplanned MonarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

Hope S. Rugo, MD;Nadia Harbeck, MD, PhD;Priya Rastogi, MD;Joyce O’Shaughnessy, MD;Frances Boyle;Javier Cortés, MD;Matthew P. Goetz, MD;Erika P. Hamilton, MD;Chiun-Sheng Huang;Elżbieta Senkus;Alexey Tryakin;Patrick Neven, MD, PhD;Jens Huober, MD;Ran Wei;Valérie André;Maria Munoz;Belen San Antonio;Ashwin Shahir;Miguel Martin, MD, PhD;Stephen Johnston
July 9th 2024
36 MONARCH 3: Final Overall Survival Results of Abemaciclib Plus a Nonsteroidal Aromatase Inhibitor as First-Line Therapy for HR+/HER2– Advanced Breast Cancer

36 MONARCH 3: Final Overall Survival Results of Abemaciclib Plus a Nonsteroidal Aromatase Inhibitor as First-Line Therapy for HR+/HER2– Advanced Breast Cancer

Matthew P. Goetz, MD;Masakazu Toi;Jens Huober, MD;Joohyuk Sohn;Oliver Trédan;In Hae Park;Mario Campone;Shin-Cheh Chen;Luis Manuel Manso;Shani Paluch-Shimon;Orit C. Freedman;Joyce A. O’Shaughnessy;Xavier Pivot;Sara M. Tolaney, MD, MPH;Sara A. Hurvitz, MD;Antonio Llombart;Valérie André;Abhijoy Saha;Gertjan van Hal;Ashwin Shahir;Hiroji Iwata;Stephen R.D. Johnston
June 23rd 2024

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Metastatic Renal Cell Carcinoma With Sarcomatoid Features
Published: April 15th 2022 | Updated: October 23rd 2024
Metastatic Renal Cell Carcinoma With Sarcomatoid Features
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Published: August 13th 2011 | Updated: October 23rd 2024
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: October 23rd 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes